Skip to main content
. 2022 May 20;13:858207. doi: 10.3389/fphar.2022.858207

FIGURE 3.

FIGURE 3

The pooled HR; 95%CI and p-values for OS (lower triangle) and PFS (upper triangle) of the network meta-analysis; significant results are in bold. Abbreviation: TGP, toripalimab plus gemcitabine and cisplatin; CGP, camrelizumab plus gemcitabine and cisplatin; GP, gemcitabine plus cisplatin; OS, overall survival; PFS, progression-free survival.